Expanded eligibility for emerging therapies in sickle cell disease in the UK – crizanlizumab and voxelotor. (21st February 2022)

Record Type:: Journal Article
Title:: Expanded eligibility for emerging therapies in sickle cell disease in the UK – crizanlizumab and voxelotor. (21st February 2022)
Main Title:: Expanded eligibility for emerging therapies in sickle cell disease in the UK – crizanlizumab and voxelotor
Authors:: Vora, Sona M.
Boyd, Stephen
Denny, Nicholas
Jackson, Elizabeth
Roy, Noemi B. A.
Howard, Jo
Lugthart, Sanne
Abstract:
Is Part Of:: British journal of haematology. Volume 197:Number 4(2022)
Journal:: British journal of haematology
Issue:: Volume 197:Number 4(2022)
Issue Display:: Volume 197, Issue 4 (2022)
Year:: 2022
Volume:: 197
Issue:: 4
Issue Sort Value:: 2022-0197-0004-0000
Page Start:: 502
Page End:: 504
Publication Date:: 2022-02-21
Subjects:: Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15
Journal URLs:: http://www.blacksci.co.uk/%7Ecgilib/jnlpage.bin?Journal=bjh&File=bjh&Page=aims ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjh.18059 ↗
Languages:: English
ISSNs:: 0007-1048
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2309.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 21352.xml